| Nov 19 |
Is InflaRx N.V. (IFRX) the Best German Stock to Buy Now?
|
| Nov 15 |
InflaRx receives positive CHMP opinion for SARS-CoV-2-induced acute respiratory distress treatment
|
| Nov 15 |
InflaRx Receives Positive CHMP Opinion for GOHIBIC® (Vilobelimab) for the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome
|
| Nov 14 |
Prenetics Global And 2 Other US Penny Stocks To Watch
|
| Nov 13 |
InflaRx Reports Q3 2024 Financial Results and Progress
|
| Nov 10 |
We're A Little Worried About InflaRx's (NASDAQ:IFRX) Cash Burn Rate
|
| Nov 9 |
InflaRx expects cash to fund operations into 2026
|
| Nov 8 |
InflaRx N.V. (IFRX) Reports Q3 Loss, Tops Revenue Estimates
|
| Nov 8 |
InflaRx reports Q3 results
|
| Nov 8 |
InflaRx Reports Third Quarter 2024 Financial Results and Provides Business Update
|
